These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37243682)
61. What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer? Desnous B; Lenoir M; Bitton JY; Arbour M; Villeneuve N; Whiting S; Mohammed I; Wirrell EC; Bello-Espinosa L; Ronen GM; Lortie A; Birca A Seizure; 2021 Oct; 91():503-506. PubMed ID: 34371246 [TBL] [Abstract][Full Text] [Related]
62. Behavioral problems and family distress in tuberous sclerosis complex. Uematsu M; Numata-Uematsu Y; Aihara Y; Kobayashi T; Fujikawa M; Togashi N; Shiihara T; Ohashi K; Hattori A; Saitoh S; Kure S Epilepsy Behav; 2020 Oct; 111():107321. PubMed ID: 32698109 [TBL] [Abstract][Full Text] [Related]
63. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome. Sánchez Fernández I; Amengual-Gual M; Barcia Aguilar C; Romeu A; Sheikh T; Torres A; Chao J; Jonas R; Gaínza-Lein M; Harini C; Douglass L Epilepsia; 2023 Mar; 64(3):630-640. PubMed ID: 36600453 [TBL] [Abstract][Full Text] [Related]
64. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial. Kotulska K; Kwiatkowski DJ; Curatolo P; Weschke B; Riney K; Jansen F; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Sijko K; Głowacka-Walas J; Borkowska J; Sadowski K; Domańska-Pakieła D; Moavero R; Hertzberg C; Hulshof H; Scholl T; Benova B; Aronica E; de Ridder J; Lagae L; Jóźwiak S; Ann Neurol; 2021 Feb; 89(2):304-314. PubMed ID: 33180985 [TBL] [Abstract][Full Text] [Related]
65. Visual field constriction on vigabatrin. Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799 [TBL] [Abstract][Full Text] [Related]
67. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex. Whitney R; Jan S; Zak M; McCoy B Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505 [TBL] [Abstract][Full Text] [Related]
68. Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study. Samueli S; Dressler A; Gröppel G; Scholl T; Feucht M Epilepsia; 2018 Sep; 59(9):e142-e146. PubMed ID: 30098008 [TBL] [Abstract][Full Text] [Related]
69. Focal Epilepsy in Children With Tuberous Sclerosis Complex: Does Vigabatrin Control Focal Seizures? Lin S; Liao J; Zhao X; Hu Y; Chen L; Chen Y; Liu G; Yao Y; Su Q; Scheffer IE; Wen F J Child Neurol; 2022 Apr; 37(5):329-333. PubMed ID: 35321578 [TBL] [Abstract][Full Text] [Related]
72. [Treatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: apropos of 70 infants]. Villeneuve N; Soufflet C; Plouin P; Chiron C; Dulac O Arch Pediatr; 1998 Jul; 5(7):731-8. PubMed ID: 9759271 [TBL] [Abstract][Full Text] [Related]
73. Vigabatrin versus carbamazepine monotherapy for epilepsy. Xiao Y; Gan L; Wang J; Luo M; Luo H Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008781. PubMed ID: 26580100 [TBL] [Abstract][Full Text] [Related]
74. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex. Józwiak S; Domańska-Pakieła D; Kotulska K; Kaczorowska M Epilepsia; 2007 Aug; 48(8):1632; author reply 1632-4. PubMed ID: 17692054 [No Abstract] [Full Text] [Related]
75. Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Aronica E; Specchio N; Luinenburg MJ; Curatolo P Brain; 2023 Jul; 146(7):2694-2710. PubMed ID: 36806388 [TBL] [Abstract][Full Text] [Related]
76. Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex. Amin S; Ruban-Fell B; Newell I; Evans J; Vyas K; Nortvedt C; Chin RF Orphanet J Rare Dis; 2024 Feb; 19(1):89. PubMed ID: 38409029 [TBL] [Abstract][Full Text] [Related]
77. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype. Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195 [TBL] [Abstract][Full Text] [Related]
78. The latest on infantile spasms. Riikonen R Curr Opin Neurol; 2005 Apr; 18(2):91-5. PubMed ID: 15791136 [TBL] [Abstract][Full Text] [Related]
79. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients]. López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724 [TBL] [Abstract][Full Text] [Related]
80. Medical treatment of patients with infantile spasms. Mikati MA; Lepejian GA; Holmes GL Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]